Conestoga Capital Advisors’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Hold |
65,017
| – | – | 0.02% | 79 |
|
2025
Q1 | $1.48M | Hold |
65,017
| – | – | 0.02% | 74 |
|
2024
Q4 | $1.69M | Sell |
65,017
-220
| -0.3% | -$5.71K | 0.02% | 73 |
|
2024
Q3 | $1.63M | Hold |
65,237
| – | – | 0.02% | 70 |
|
2024
Q2 | $1.4M | Sell |
65,237
-240
| -0.4% | -$5.14K | 0.02% | 77 |
|
2024
Q1 | $1.21M | Buy |
65,477
+630
| +1% | +$11.7K | 0.02% | 87 |
|
2023
Q4 | $1.05M | Buy |
64,847
+2,585
| +4% | +$42K | 0.02% | 94 |
|
2023
Q3 | $860K | Hold |
62,262
| – | – | 0.01% | 95 |
|
2023
Q2 | $1.38M | Sell |
62,262
-10,665
| -15% | -$236K | 0.02% | 75 |
|
2023
Q1 | $1.59M | Hold |
72,927
| – | – | 0.03% | 71 |
|
2022
Q4 | $1.33M | Hold |
72,927
| – | – | 0.02% | 77 |
|
2022
Q3 | $1.66M | Sell |
72,927
-8,620
| -11% | -$196K | 0.03% | 74 |
|
2022
Q2 | $1.13M | Buy |
81,547
+24,182
| +42% | +$334K | 0.02% | 88 |
|
2022
Q1 | $1.3M | Buy |
57,365
+5,655
| +11% | +$129K | 0.02% | 90 |
|
2021
Q4 | $1.93M | Buy |
51,710
+9,300
| +22% | +$347K | 0.03% | 80 |
|
2021
Q3 | $1.8M | Sell |
42,410
-8,100
| -16% | -$343K | 0.02% | 84 |
|
2021
Q2 | $2.25M | Buy |
50,510
+1,125
| +2% | +$50.1K | 0.03% | 80 |
|
2021
Q1 | $1.78M | Hold |
49,385
| – | – | 0.03% | 85 |
|
2020
Q4 | $1.97M | Sell |
49,385
-6,150
| -11% | -$245K | 0.03% | 76 |
|
2020
Q3 | $1.61M | Buy |
55,535
+2,550
| +5% | +$73.8K | 0.03% | 76 |
|
2020
Q2 | $866K | Buy |
52,985
+22,425
| +73% | +$367K | 0.02% | 95 |
|
2020
Q1 | $290K | Buy |
30,560
+750
| +3% | +$7.12K | 0.01% | 124 |
|
2019
Q4 | $482K | Buy |
29,810
+15,425
| +107% | +$249K | 0.01% | 115 |
|
2019
Q3 | $239K | Buy |
14,385
+575
| +4% | +$9.55K | 0.01% | 137 |
|
2019
Q2 | $234K | Buy |
13,810
+490
| +4% | +$8.3K | 0.01% | 141 |
|
2019
Q1 | $238K | Buy |
+13,320
| New | +$238K | 0.01% | 137 |
|